THE INTEGRATION OF RADIOTHERAPY INTO THE PRIMARY-TREATMENT OF NON-HODGKINS-LYMPHOMA

被引：17

作者：

MIRZA, MR

BRINCKER, H

SPECHT, L

机构：

[1] ODENSE UNIV HOSP,DEPT ONCOL & HEMATOL,DK-5000 ODENSE,DENMARK

[2] AGA KHAN UNIV,FAC HLTH SCI,COLL MED,KARACHI,PAKISTAN

[3] HERLEV UNIV HOSP,DEPT ONCOL,HERLEV,DENMARK

来源：

CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | 1992年 / 12卷 / 03期

关键词：

D O I：

10.1016/1040-8428(92)90055-U

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：217 / 229

页数：13

共 135 条

[31]

EBY NL, 1988, CANCER, V62, P2461, DOI 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO

[32]

2-M

[33] PROGNOSTIC FACTORS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA FOLLOWING TREATMENT WITH COMBINATION CHEMOTHERAPY [J].

FISHER, RI ;

DEVITA, VT ;

JOHNSON, BL ;

SIMON, R ;

YOUNG, RC .

AMERICAN JOURNAL OF MEDICINE, 1977, 63 (02) :177-182

[34]

FLEMING ID, 1982, CANCER, V49, P1135, DOI 10.1002/1097-0142(19820315)49:6<1135::AID-CNCR2820490612>3.0.CO

[35]

2-E

[36] RECURRENCE RATES FOLLOWING RADIATION-THERAPY OF NODULAR AND DIFFUSE MALIGNANT LYMPHOMAS [J].

FUKS, Z ;

KAPLAN, HS .

RADIOLOGY, 1973, 108 (03) :675-684

[37]

FULLER LM, 1975, BRIT J CANCER, V31, P270

[38]

GOBBI PG, 1990, CANCER, V65, P2528, DOI 10.1002/1097-0142(19900601)65:11<2528::AID-CNCR2820651123>3.0.CO

[39]

2-W

[40] TREATMENT OF EARLY STAGE-I AND STAGE-II NODULAR, POORLY DIFFERENTIATED LYMPHOCYTIC LYMPHOMA [J].

GOMEZ, GA ;

BARCOS, M ;

KRISHNAMSETTY, RM ;

PANAHON, AM ;

HAN, T ;

HENDERSON, ES .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01) :40-44

← 1 2 3 4 5 6 7 8 9 10 →